falseQ20001856242--12-31DC 0001856242 2023-01-01 2023-06-30 0001856242 2022-01-01 2022-06-30 0001856242 2023-06-30 0001856242 2022-12-31 0001856242 2023-04-01 2023-06-30 0001856242 2022-04-01 2022-06-30 0001856242 2022-01-01 2022-03-31 0001856242 2022-01-11 0001856242 2022-01-11 2022-01-11 0001856242 2023-01-01 2023-03-31 0001856242 2023-05-01 2023-05-31 0001856242 2023-04-01 2023-04-30 0001856242 2021-12-31 0001856242 2022-06-30 0001856242 2023-03-31 0001856242 2022-03-31 0001856242 us-gaap:CommonClassAMember 2023-06-30 0001856242 us-gaap:CommonClassBMember 2023-06-30 0001856242 cxac:SponsorMember us-gaap:CommonClassAMember cxac:RestrictionOnTransferOfSponsorSharesMember 2023-06-30 0001856242 cxac:MayExtensionPromissoryNoteMember cxac:SponsorMember 2023-06-30 0001856242 cxac:ExtensionPromissoryNoteMember cxac:SponsorMember 2023-06-30 0001856242 cxac:PrivatePlacementWarrantMember cxac:PromissoryNoteMember cxac:SponsorMember 2023-06-30 0001856242 us-gaap:AccountsPayableAndAccruedLiabilitiesMember cxac:SponsorMember 2023-06-30 0001856242 cxac:SponsorMember cxac:WorkingCapitalLoansMember 2023-06-30 0001856242 cxac:SponsorMember cxac:PrivatePlacementWarrantMember 2023-06-30 0001856242 cxac:PrivatePlacementWarrantMember us-gaap:CommonClassAMember 2023-06-30 0001856242 cxac:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2023-06-30 0001856242 us-gaap:IPOMember 2023-06-30 0001856242 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-06-30 0001856242 cxac:PublicWarrantsMember 2023-06-30 0001856242 cxac:UnderwritingAgreementMember 2023-06-30 0001856242 cxac:VendorAgreementsMember 2023-06-30 0001856242 cxac:PromissoryNoteMember cxac:PrivatePlacementWarrantMember cxac:SponsorMember 2023-06-30 0001856242 cxac:SponsorMember cxac:PromissoryNoteMember 2023-06-30 0001856242 us-gaap:CommonClassAMember 2022-12-31 0001856242 us-gaap:CommonClassBMember 2022-12-31 0001856242 cxac:SponsorMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-12-31 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001856242 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001856242 us-gaap:RelatedPartyMember 2023-04-01 2023-06-30 0001856242 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001856242 us-gaap:CommonClassBMember 2023-04-01 2023-06-30 0001856242 us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001856242 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001856242 us-gaap:RelatedPartyMember 2022-04-01 2022-06-30 0001856242 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001856242 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001856242 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001856242 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001856242 us-gaap:CapitalUnitsMember 2023-01-01 2023-06-30 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001856242 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001856242 cxac:RestrictionOnTransferOfSponsorSharesMember us-gaap:CommonClassAMember cxac:SponsorMember 2023-01-01 2023-06-30 0001856242 cxac:SponsorMember cxac:AdministrationAndSupportServicesMember 2023-01-01 2023-06-30 0001856242 us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0001856242 us-gaap:IPOMember 2023-01-01 2023-06-30 0001856242 us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001856242 cxac:SponsorMember cxac:PrivatePlacementWarrantMember 2023-01-01 2023-06-30 0001856242 cxac:PrivatePlacementWarrantMember 2023-01-01 2023-06-30 0001856242 cxac:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2023-01-01 2023-06-30 0001856242 us-gaap:CommonClassBMember 2023-01-01 2023-06-30 0001856242 us-gaap:IPOMember cxac:PublicWarrantsMember cxac:FromTheCompletionOfBusinessCombinationMember 2023-01-01 2023-06-30 0001856242 cxac:FromTheCompletionOfBusinessCombinationMember cxac:PublicWarrantsMember 2023-01-01 2023-06-30 0001856242 cxac:PublicWarrantsMember 2023-01-01 2023-06-30 0001856242 cxac:PrivatePlacementWarrantsMember 2023-01-01 2023-06-30 0001856242 cxac:UnderwritingAgreementMember 2023-01-01 2023-06-30 0001856242 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-06-30 0001856242 cxac:SponsorMember 2023-01-01 2023-06-30 0001856242 cxac:WorkingCapitalLoansMember 2023-01-01 2023-06-30 0001856242 cxac:WorkingCapitalLoansMember 2023-01-01 2023-06-30 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001856242 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001856242 us-gaap:RelatedPartyMember 2022-01-01 2022-06-30 0001856242 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001856242 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001856242 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001856242 cxac:PrivateWarrantsMember 2022-01-01 2022-03-31 0001856242 cxac:PrivateWarrantsMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001856242 cxac:PublicWarrantsMember 2022-01-01 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember cxac:PublicWarrantsMember 2022-01-01 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001856242 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001856242 us-gaap:OverAllotmentOptionMember 2022-01-11 2022-01-11 0001856242 us-gaap:IPOMember 2022-01-11 2022-01-11 0001856242 us-gaap:PrivatePlacementMember 2022-01-11 2022-01-11 0001856242 cxac:PrivatePlacementWarrantsMember 2022-01-11 2022-01-11 0001856242 cxac:PublicWarrantsMember 2022-01-11 2022-01-11 0001856242 us-gaap:IPOMember 2022-01-11 0001856242 us-gaap:CommonClassAMember 2022-01-11 0001856242 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-11 0001856242 us-gaap:PrivatePlacementMember 2022-01-11 0001856242 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-11 0001856242 cxac:AgreementToAmendAndRestateTheCertificateOfIncorporationMember us-gaap:CommonClassAMember 2023-04-06 2023-04-06 0001856242 us-gaap:CommonClassAMember cxac:AgreementToAmendAndRestateTheCertificateOfIncorporationMember 2023-04-06 0001856242 cxac:AgreementToAmendAndRestateTheCertificateOfIncorporationMember 2023-04-06 0001856242 cxac:FounderSharesMember cxac:SponsorMember us-gaap:CommonClassBMember 2021-05-18 2021-05-18 0001856242 cxac:SponsorMember cxac:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-05-18 2021-05-18 0001856242 cxac:SponsorMember cxac:FounderSharesMember 2021-05-18 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2021-05-20 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2021-06-04 2021-06-04 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2023-05-10 0001856242 cxac:TrancheTwoMember 2023-05-10 0001856242 cxac:TrancheOneMember 2023-05-10 0001856242 cxac:SponsorMember cxac:PromissoryNoteMember 2023-05-10 0001856242 cxac:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-01-06 0001856242 us-gaap:CommonClassBMember 2023-11-01 0001856242 us-gaap:CommonClassAMember 2023-11-01 0001856242 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2023-10-26 0001856242 us-gaap:SubsequentEventMember 2023-10-26 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001856242 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001856242 us-gaap:RetainedEarningsMember 2023-06-30 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001856242 us-gaap:RetainedEarningsMember 2022-06-30 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001856242 us-gaap:RetainedEarningsMember 2022-12-31 0001856242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001856242 us-gaap:RetainedEarningsMember 2023-03-31 0001856242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001856242 us-gaap:RetainedEarningsMember 2021-12-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001856242 us-gaap:RetainedEarningsMember 2022-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month utr:Year iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(MARK ONE)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission

File Number:

001-41205

C5 Acquisition Corporation

(Exact name of registrant as specified in its charter)


Delaware		86-3097106
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1701 Pennsylvania Ave NW, Ste #460

Washington, D.C. 20006

(Address of principal executive offices, including zip code)

(202)

452-9133

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant	CXAC.U	New York Stock Exchange
Class A Common Stock, $0.0001 par value	CXAC	New York Stock Exchange
Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share	CXAC WS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90

days.

Yes

☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit

such files)..

Yes

☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller

reporting

company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange

Act.

☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange

Act). Yes

☒

No ☐

As o

f November 1,

2023 there were

0 shares of Class A common stock, $0.0001 par value, and 7,187,500 shares of Class B

common

stock, $0.0001 par value, issued and outstanding.

C5 ACQUISITION CORPORATION

FORM 10-Q FOR THE QUARTER ENDED June 30, 2023

TABLE OF CONTENTS


	Page
PART I - FINANCIAL INFORMATION		1

Item 1. Interim Financial Statements		1

Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022		1

Condensed Statements of Operations for the Three and Six Months ended June 30, 2023 and 2022 (Unaudited)		2

Condensed Statements of Changes in Stockholders’ Deficit for the Six Months ended June 30, 2023 and 2022 (Unaudited)		3

Condensed Statements of Cash Flows for the Six Months ended June 30, 2023 and 2022 (Unaudited)		4

Notes to the Condensed Financial Statements (Unaudited)		5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17

Item 3. Quantitative and Qualitative Disclosures About Market Risk		21

Item 4. Controls and Procedures		21

PART II - OTHER INFORMATION		22

Item 1. Legal Proceedings		22

Item 1A. Risk Factors		22

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		22

Item 3. Defaults Upon Senior Securities		22

Item 4. Mine Safety Disclosures		22

Item 5. Other Information.		22

Item 6. Exhibits		23

PART III - SIGNATURES		24

-i-

PART

I-FINANCIAL

INFORMATION

Item 1.

Interim Financial Statements

C5 ACQUISITION CORPORATION

CONDENSED BALANCE SHEETS


	June 30, 2023 (unaudited)			December 31, 2022
ASSETS
Current Assets:
Cash	$	766		$	935,721
Prepaid expenses		301,045			597,422

Total Current Assets		301,811			1,533,143
Investments held in the Trust Account		99,163,964			297,415,415

Total Assets	$	99,465,775		$	298,948,558

LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable and accrued expenses	$	819,711		$	448,459
Excise tax payable		2,032,423			—
Income taxes payable		1,018,755			750,853

Convertible promissory notes – related party		370,000			—

Total Current Liabilities		4,240,889			1,199,312
Deferred underwriting commission		10,062,500			10,062,500

Total liabilities		14,303,389			11,261,812
COMMITMENTS AND CONTINGENCIES (Note 6)
Class A common stock subject to possible redemption; 9,294,308 and 28,750,000 at June 30, 2023 and December 31, 2022, respectively (at redemption value of $10.55 and $10.31 per share, respectively)		98,030,311			296,464,562
Stockholders’ Deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, none issued and outstanding at June 30, 2023 and December 31, 2022 (excluding 9,294,308 and 28,750,000 shares subject to possible redemption, respectively)		—			—
Class B common stock, $0.0001 par value, 100,000,000 shares authorized, 7,187,500 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively		719			719
Additional paid-in capital		—			—
Accumulated deficit		(12,868,644	)		(8,778,535	)

Total Stockholders’ Deficit		(12,867,925	)		(8,777,816	)

Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$	99,465,775		$	298,948,558

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

C5 ACQUISITION CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)


	For the Three Months Ended					For the Six Months Ended
	June 30,					June 30,
	2023		2022			2023		2022
EXPENSES
Administrative fee - related party	$	105,000	$	105,000		$	210,000	$	197,581
General and administrative		511,039		353,558			988,291		762,850

TOTAL EXPENSES		616,039		458,558			1,198,291		960,431

OTHER INCOME
Income earned on Investments held in Trust Account		1,816,603		332,829			4,971,568		379,595

TOTAL OTHER INCOME		1,816,603		332,829			4,971,568		379,595

Net income (loss) before income tax provision		1,200,564		(125,729	)		3,773,277		(580,636	)

Income tax provision		370,987		17,482			1,022,902		17,482

Net income (loss)	$	829,577	$	(143,211	)	$	2,750,375	$	(598,318	)

Basic and diluted weighted average shares outstanding, Class A Common Stock		15,066,876		28,750,000			21,870,639		27,002,762

Basic and diluted net income (loss) per share of Class A Common Stock	$	0.04	$	(0.01	)	$	0.09	$	(0.03	)

Weighted average number of shares of Class B Common Stock outstanding, basic and diluted		7,187,500		7,187,500			7,187,500		7,130,525

Basic and diluted net income (loss) per share of Class B Common Stock	$	0.04	$	(0.01	)	$	0.09	$	(0.03	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

C5 ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE SIX MONTHS ENDED JUNE 30, 2023


	Class B				Additional
	Common Stock				Paid-In		Accumulated			Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance as of January 1, 2023		7,187,500	$	719	$	—	$	(8,778,535	)	$	(8,777,816	)
Accretion of Class A common stock to redemption amount		—		—		—		(2,452,445	)		(2,452,445	)
Net incom e		—		—		—		1,920,798			1,920,798

Balance as of March 31, 2023		7,187,500		719		—		(9,310,182	)		(9,309,463	)
Accretion of Class A common stock to redemption amount		—		—		—		(4,388,039	)		(4,388,039	)
Net income		—		—		—		829,577			829,577

Balance as of June 30, 2023		7,187,500	$	719	$	—	$	(12,868,644	)	$	(12,867,925	)

FOR THE SIX MONTHS ENDED JUNE 30, 2022


	Class B				Additional
	Common Stock				Paid-In			Accumulated			Stockholder’s
	Shares		Amount		Capital			Deficit			Deficit
Balance as of January 1, 2022		7,187,500	$	719	$	24,281		$	(21,784	)	$	3,216
Proceeds Allocated to Public Warrants						11,514,821			—			11,514,821
Proceeds from Private Warrants, net of offering costs		—		—		15,007,880			—			15,007,880
Value of transaction costs allocated to the fair value of equity instruments		—		—		(654,468	)		—			(654,468	)
Remeasurement adjustment of Class A common stock to redemption value		—		—		(25,892,514	)		(7,058,480	)		(32,950,994	)
Accretion of Class A common stock to redemption amount		—		—		—			(46,766	)		(46,766	)
Net loss		—		—		—			(455,107	)		(455,107	)

Balance as of March 31, 2022		7,187,500		719		—			(7,582,137	)		(7,581,418	)
Accretion of Class A common stock to redemption amount		—		—		—			(297,691	)		(297,691	)
Net loss		—		—		—			(143,211	)		(143,211	)

Balance as of June 30, 2022		7,187,500	$	719	$	—		$	(8,023,039	)	$	(8,022,320	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

C5 ACQUISITION CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)


				For the Six
	For the Six			Months
	Months Ended			Ended June 30,
	June 30, 2023			2022
Cash Flows From Operating Activities:
Net income (loss)	$	2,750,375		$	(598,318	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income earned on Investments held in Trust Account		(4,971,568	)		(379,595	)
Changes in operating assets and liabilities:
Prepaid expenses		296,377			(648,654	)
Other assets		—			(309,180	)
Income tax payable		267,902			—
Accounts payable and accrued expenses		371,252			175,054

Net Cash Used In Operating Activities		(1,285,662	)		(1,760,693	)

Cash Flows From Investing Activities:
Cash deposited into Trust Account		(960,000	)		(293,250,000	)
Cash drawn for redemptions		203,242,313			—
Cash withdrawn from Trust Account for taxes		940,707			17,656

Net Cash Provided By (Used In) Investing Activities		203,223,020			(293,232,344	)

Cash Flows From Financing Activities:
Sale of Units in the Initial Public Offering, net of underwriting discount		—			281,750,000
Cash paid for redemptions of Class A common stock		(203,242,313	)		—
Sale of Private Placement Warrants to Sponsor		—			15,035,500
Repayment of Sponsor promissory note		—			(300,000	)
Payment of offering costs		—			(444,754	)
Proceeds from convertible promissory notes – related party		370,000			—

Net Cash (Used In) Provided By Financing Activities		(202,872,313	)		296,040,746

Net change in cash		(934,955	)		1,047,709
Cash at beginning of period		935,721			210,351

Cash at end of period	$	766		$	1,258,060

Supplemental disclosure of cash flow information:
Cash paid for taxes	$	948,563		$	—
Supplemental disclosure of non-cash financing activities:
Deferred offering costs included in accrued offering costs	$	—		$	10,062,500
Class A Common Stock measurement adjustment	$	—		$	32,950,994
Accretion of Class A common stock to redemption value	$	6,840,484		$	344,457
Offering costs included in accounts payable and accrued expenses	$	—		$	395

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

C5 ACQUISITION CORPORATION

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

NOTE 1 — DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN

C5 Acquisition Corporation (the “Company”) was incorporated in Delaware on March 30, 2021. The Company was formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

All activity for the period from March 30, 2021 (inception) through June 30, 2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”) as described below and search for a target company. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate

non-operating

income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

On January 11, 2022, the Company consummated the Initial Public Offering of 28,750,000 units (“Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $287,500,000, which is described in Note 3. This included an additional 3,750,000 Units purchased by the underwriters pursuant to the exercise of their option to purchase additional units (the “Over- Allotment Option”) in full.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) of an aggregate of 15,035,500 warrants (the “Private Placement Warrants”) to C5 Sponsor LLC (the “Sponsor”) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $15,035,500, which is described in Note 4.

Transaction costs related to the Initial Public Offering amounted to $16,368,261 consisting of $5,750,000 of underwriting fees, $10,062,500 of deferred underwriting fees payable (which are held in a trust account with Continental Stock Transfer & Trust Company acting as trustee (the “Trust Account”) and $555,761 of other costs related to the Initial Public Offering.

Following the closing of the Initial Public Offering on January 11, 2022, an amount of $293,250,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in the Trust Account, which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule

2a-7

of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.

The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management has agreed that an amount equal to at least $10.20 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants, will be held in the Trust Account.

Table of Contents

The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection

with the Business Combination. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender of

fer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC

480-10-S99,

redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC

470-20.

The Class A common stock is subject to ASC

480-10-S99.

If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional

paid-in

capital). The Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place. Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination.

The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to the Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its second amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Table of Contents

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or

pre-business

combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company has not completed a Business Combination by December 31, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The Sponsor has agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit

10.00

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

At the special meeting of the stockholders of the Company held on April 6, 2023 (the “Special Meeting”), stockholders of the Company approved an amendment to the Company’s amended and restated certificate of incorporation (the “Charter”) to extend the date by which the Company has to consummate a Business Combination from April 11, 2023 to December 31, 2023 (or such earlier date as determined by the Company’s board of directors) (the “Charter Amendment”).

In connection with the vote to approve the Charter Amendment, holders of 19,455,692 shares of Class A common stock exercised their right to redeem their shares for cash at a redemption price of approximately $10.45 per share, for an aggregate redemption amount of approximately $203.2 million. As a result, approximately $203.2 million was removed from the Trust Account to redeem such shares and 9,294,308 shares of Class A common stock remained outstanding after the redemption was effected. Upon payment of the redemption, approximately $97.8 million remained in the Trust Account.

Following the Charter Amendment, the Company or the Sponsor will make monthly deposits directly to the Trust Account in the amount of $

320,000

(

each deposit, a “Contribution”). Deposits may be made by the Sponsor or from cash held outside of the trust. Each Contribution will be paid monthly beginning on April 11, 2023 and thereafter on the eleventh day of each month (or if such eleventh day is not a business day, on the business day immediately preceding such eleventh day) until the earliest to occur of (i) the consummation of a business combination, (ii) December 11, 2023 and (iii) if a business combination is not consummated, the date of liquidation of the Trust Account, as determined in the sole discretion of the Company’s board of director

On May 10, 2023, our Sponsor agreed to make advances of up to an aggregate of $

2,880,000

in respect of the Contributions pursuant to a

non-interest

bearing, promissory note (the “Promissory Note”) issued by us to our Sponsor. At the election of the Sponsor, up to $

2,000,000

of the principal amount of the Promissory Note may be converted into private placement warrants of the Company. The Promissory Note will mature on the earlier of (1) the date the Company consummates a business combination and (2) the date that the winding up of the Company is effective (such date, the “Maturity Date”).

The Promissory Note will not bear any interest, and will be repayable by the Company to the Sponsor upon the Maturity Date. The Maturity Date may be accelerated upon the occurrence of an “Event of Default” (as defined in the Promissory Note). Any outstanding principal under the Promissory Note may be prepaid at any time by the Company, at its election and without penalty.

In each of April, May and June 2023, $320,000

was deposited into the Trust Account in accordance with the conditions of the extensio

n. The Company paid the April extension payment of $320,000 out of working capital. I

n connection with the May extension payment

the Company borrowed $50,000

against the promissory note and paid $270,000 in to the trust account from funds for working capital.

In connection with the June extension payment

the Company borrowed $

320,000

against the promissory note. The promissory note has a balance of $

370,000

as of June 30, 2023.

Table of Contents

Going Concern

In connection with the Co

mpa

ny’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)

2014-15,

“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently has less than 12 months from the date these financial statements were issued to complete a Business Combination within the Combination Period (the completion window currently ends on December 31, 2023), the mandatory liquidation requirement that the Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. Management has determined that the Company does not have funds that are sufficient to fund the working capital needs of the Company until the consummation of an initial Business Combination or the winding up of the Company as stipulated in the Company’s amended and restated certificate of incorporation. The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. These unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risks and Uncertainties

Management is currently evaluating the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.

Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed. As such, the information included in these financial statements should be read in conjunction with the audited financial statements as of December 31, 2022 filed with the SEC on Form

10-K.

In the opinion of the Company’s management, these condensed financial statements include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the Company’s financial position as of June 30, 2023 and the Company’s results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2023 not necessarily indicative of the results to be expected for the full year ending December 31, 2023.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Table of Contents

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The Company has determined that its more significant accounting estimates included in these financial statements is the valuation of warrants and the valuation of deferred tax assets. Accordingly, the actual results could differ significantly from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Offering Costs associated with Initial Public Offering

The Company complies with the requirements of the Financial Accounting Standards Board ASC

340-10-S99-1

and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, “Expenses of Offering.” Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Units were allocated between temporary equity and the Public Warrants by the relative fair value method. Offering costs of $555,761 consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $15,812,500, were allocated between temporary equity, the Public Warrants and the Private Warrants in a relative fair value method upon completion of the Initial Public Offering.

Warrants

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own Class A common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

All of the Company’s warrants have met the criteria for equity treatment.

Table of Contents

Class A common stock subject to possible redemption

The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The shares of the Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023, the shares of Class A common stock subject to possible redemption in the amount of $98,030,311 are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of Class A Common Stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A Common Stock resulted in charges against accumulated deficit.

Convertible Promissory Notes

The Company has determined that under ASC 815 “Derivatives and Hedging”, the promissory note has no equity host characteristics and as such will be accounted for as a liability. The Company carries the note at cost. The Company has determined that the warrant conversion feature is an embedded derivative that is not required to be bifurcated and separately accounted for under ASC 815.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

In conn

ectio

n with the redemption, the Company recorded excise tax of $2.0 million. To the extent the Company issues shares during the year ended December 31, 2023, including in connection with the business combination noted below, it likely will reduce the excise tax liability.

Table of Contents

Net Income (Loss) per Common Share

two-class

method in calculating earnings per share. The remeasurement adjustment associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted earnings per share of common stock is the same as basic earnings per common stock for the periods presented. As of June 30, 2023 and 2022, the warrants are exercisable to purchase 29,410,500 shares of Class A common stock in the aggregate.

The following table reflects the calculation of basic and diluted net income (loss) per share of common stock.


	Three Months Ended June 30, 2023		Three Months Ended June 30, 2022
Class A Common Stock
Numerator: Income (loss) allocable to Class A Common Stock, $	$	561,648	$	(380,832	)
Denominator: Basic and diluted weighted average shares outstanding		15,066,876		28,750,000

Basic and diluted net income (loss) per share, Class A Common Stock	$	0.04	$	(0.01	)

Class B Common Stock
Numerator: Income (loss) allocable to Class B Common Stock,		267,929		(95,208	)
Denominator: Basic and diluted weighted average shares outstanding		7,187,500		7,187,500

Basic and diluted net income (loss) per share, Class B Common Stock	$	0.04	$	(0.01	)


	Six Months Ended June 30, 2023		Six Months Ended June 30, 2022
Class A Common Stock
Numerator: Income (loss) allocable to Class A Common Stock, $	$	2,070,073	$	(773,625	)
Denominator: Basic and diluted weighted average shares outstanding		21,870,639		27,002,762

Basic and diluted net income (loss) per share, Class A Common Stock	$	0.09	$	(0.03	)

Class B Common Stock
Numerator: Income (loss) allocable to Class B Common Stock,		680,302		(204,288	)
Denominator: Basic and diluted weighted average shares outstanding		7,187,500		7,130,525

Basic and diluted net income (loss) per share, Class B Common Stock	$	0.09	$	(0.03	)

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Table of Contents

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial stateme

nts.

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on January 11, 2022, the Company sold 28,750,000 Units at a purchase price of $10.00 per Unit generating gross proceeds to the Company in the amount of $287,500,000. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class A common stock”), and

one-half

of one redeemable public warrant of the Company (each whole public warrant, a “Public Warrant”), with each whole Public Warrant entitling the holder thereof to purchase one whole share of Class A Common Stock at a price of $11.50 per share, subject to adjustment.

This included an additional 3,750,000 Units purchased by the underwriters pursuant to the exercise of their option to purchase additional units (the “Over-Allotment Option”) in full generating gross proceeds of $37,500,000.

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of an aggregate of 15,035,500 Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $15,035,500. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination, subject to certain exceptions.

NOTE 5 — RELATED PARTIES

Founder Shares

On May 18, 2021, the Sponsor received 7,187,500 of the Company’s Class B common stock (the “Founder Shares”) for $25,000. The Founder Shares include an aggregate of up to 937,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will equal, on an

as-converted

basis, approximately 20% of the Company’s issued and outstanding shares of common stock after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their overallotment option on January 6, 2022, no Founder Shares were subject to forfeiture (see Note 6).

The

Sponsor h

as agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Table of Contents

Promissory Note — Related Party

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be

used to repay the Working Capital Loans

On May 20, 2021, the Sponsor issued an unsecured promissory note to the Company (as amended, the “IPO Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The IPO Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022 or (ii) the consummation of the Initial Public Offering. On June 4, 2021, the Company borrowed $300,000 under the IPO Promissory Note. On January 11, 2022, the amount outstanding under the IPO Promissory Note was paid in full.

On May 10, 2023, our Sponsor agreed to make advances of up to an aggregate of

$2,880,000

in respect of the Contributions pursuant to a non-interest bearing, promissory note (the “Promissory Note”) issued by us to our Sponsor. At the election of the Sponsor, up to

$2,000,000

The Maturity Date may be accelerated upon the occurrence of an “Event of Default” (as defined in the Promissory Note). Any outstanding principal under the Promissory Note may be prepaid at any time by the Company, at its election and without penalty.

In each of April, May and June 2023, $320,000 was deposited into the Trust Account in accordance with the conditions of the extensio

n. The Company paid the April extension payment of $320,000 out of working capital. I

n connection with the May extension payment, the Company borrowed $50,000 against the Promissory Note and paid $270,000 in to the Trust Account from funds for working capital.

In connection with the June extension payment

the Company borrowed $320,000 against the Promissory Note. The Promissory Note has a balance of $370,000 as of June 30, 2023.

General and Administrative Services

Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $35,000 per month for office space, utilities and secretarial and administrative support until the earlier of the completion of the initial Business Combination and the Company’s liquidation. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three and six months ended June 30, 2023, the Company recorded $105,000 and $210,000 under the service agreement, respectively. During the three and six months ended June 30, 2022, the Company recorded $105,000 and $197,581 under the service agreement, respectively. As of June 30, 2023 and December 31, 2022, there was $70,000 and $35,000 outstanding balance due to the Sponsor under the agreement, respectively.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may

be is

sued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their

lock-up

restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Table of Contents

Underwriting Agreement

The Company granted the underwriters a

45-day

option from the date of Initial Public Offering to purchase up to 3,750,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On January 11, 2022, the underwriters fully exercised their option to purchase additional units. The exercise of the option generated gross proceeds of $37,500,000 to the Company.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,750,000, upon the closing of the Initial Public Offering. In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit, or $10,062,500. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Financial Advisor Engagement

Following the completion of the Company’s Initial Public Offering, the Company entered into an engagement letter (the “Engagement Letter”) with a financial advisor in connection with an initial Business Combination and as a placement agent in connection with related private placement transactions (each, a “PIPE transaction”). In connection with the Engagement Letter and upon closing of the initial Business Combination and PIPE transaction, the Company has agreed to pay the advisor a variable transaction fee based on the value of the initial Business Combination and a transaction fee with respect to each completed PIPE transaction, in each case, pursuant to the terms of the Engagement Letter. The advisor also participated in the Company’s Initial Public Offering as an underwriter.

Vendor Agreements

As of June 30, 2023, the Company had incurred legal fees related to the Initial Public Offering and general corporate services of approximately $535,000. $190,000 of these fees will only become due and payable upon the consummation of a Business Combination. The outstanding balance of the legal fees is in accounts payable and accrued expenses on the condensed balance sheets.

On February 24, 2023, the Company entered into a finder’s fee agreement with PartnerCap Securities, LLC (“PartnerCap”), pursuant to which PartnerCap will provide information to the Company relating to a proposed Business Combination transaction. The Company has agreed to pay PartnerCap a fee only if the Company consummates a Business Combination transaction with a target identified by PartnerCap.

NOTE 7 — STOCKHOLDERS’ DEFICIT

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Class A Common Stock — The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $

0.0001

per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were

9,294,308

and

28,750,000

shares of the Class A Common Stock, respectively, that were classified as temporary equity in the accompanying condensed balance sheets.

Class B Common Stock — The Company is authorized to issue

100,000,000

shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 7,187,500 shares of Class B common stock issued and outstanding.

Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders, including the election of directors, except as otherwise required by law. In connection with our initial Business Combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.

Table of Contents

The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a

one-for-one

basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an

as-converted

basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.

Warrants —Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Public Warrants — Once the Public Warrants become exercisable, the Company may redeem the outstanding public warrants:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon a minimum of 30 days’ prior written notice of redemption, or the

30-day

redemption period to each Public Warrant holder; and

•

if, and only if, the last reported sale price of the Class A common stock has been at least $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 10 trading days within a

20-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to Public Warrant holders.

Table of Contents

The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the Public Warrants is then effective an

d a

current prospectus relating to those shares of Class A common stock is available throughout the

30-day

redemption period or the Company elected to require the exercise of the Public Warrants on a “cashless basis” as described below. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public.

Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be

non-redeemable

and will be exercisable at the election of the holder on a “cashless basis”. The warrant agreements contain a provision wherein warrant holders can receive an “alternative issuance”, including as a result of a tender offer that constitutes a change of control.

The Company accounts for the 29,410,500 warrants to be issued in connection with the Initial Public Offering (including 14,375,000 Public Warrants and 15,035,500 Private Placement Warrants) in accordance with the guidance contained in ASC

815-40.

Such guidance provides that the warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.

NOTE 8 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any other subsequent events that would have required adjustment or disclosure in these financial statements.

On October 10, 2023, the Company terminated its previously disclosed letter of intent with respect to a business combination, terminated the completion window in which it will consummate a business combination and notified Continental Stock Transfer and Trust company that it was liquidating its Trust Account and proceeding with the redemption of all of its Class A Common Stock. On October 26, 2023, the Company redeemed all of its Class A Common Stock for an aggregate of $99.8 million of cash available from the Trust Account. The cash available represented the balance of the Trust Account after deducting taxes paid or payable and $100,000 to pay dissolution expenses, and excluded $235,000 of extension contributions due on September 11 that remain in arrears as of the date hereof. The Company is considering its recourse against the Sponsor to fund such amount, but there can be no assurance that such amount will be collected.

Should the Company liquidate prior to December 31, 2023, the excise tax liability associated with redemptions during the year ended December 31, 2023 will not be due.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this Annual Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Annual Report.

Overview

We are a blank check company formed under the laws of the State of Delaware on March 30, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

Our only activities from March 30, 2021 (inception) through June 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and the search for a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2023, we had net income of $829,577, which consists of interest earned on marketable securities held in the Trust Account of $1,816,603 and partially offset by related party administration fee ($105,000), directors and officers insurance ($148,080), professional fees ($268,692), other operating costs ($44,267) franchise tax expense of ($50,000) and income taxes ($370,987).

For the three months ended June 30, 2022, we had a net loss of $143,211, which consists of operating costs of $458,558 offset by interest earned on marketable securities held in the Trust Account of $332,829. Operating costs for the three months ended June 30, 2022, consist primarily of professional fees ($102,251), related party administration fee ($105,000), directors and officers insurance ($148,080) and franchise taxes ($50,000). In addition, during the three months ended June 30, 2022, the Company recorded an income tax provision of $17,482 due to the increase in interest income during the period.

For the six months ended June 30, 2023, we had net income of $2,750,375, which consists of interest earned on marketable securities held in the Trust Account of $4,971,568 and partially offset by related party administration fee ($210,000), directors and officers insurance ($294,534), professional fees ($509,392), other operating costs ($83,759) franchise tax expense of ($100,606) and income taxes of ($1,022,902).

For the six months ended June 30, 2022, we had a net loss of $598,318, which consists of operating costs of $960,431 offset by interest earned on marketable securities held in the Trust Account of $379,595. Operating costs for the six months ended June 30, 2022, consist mostly of professional fees ($202,791), related party administration fee ($197,581), directors and officers insurance ($276,633), franchise taxes ($98,767) and listing fees ($118,662). In addition, during the six months ended June 30, 2022, the Company recorded an income tax provision of $17,482 due to the increase in interest income during the period.

Liquidity and Capital Resources

On January 11, 2022, we consummated the Initial Public Offering of 28,750,000 Units at a price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units, generating gross proceeds of $287,500,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 15,035,500 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to our Sponsor, generating gross proceeds of $15,035,500.

Following the Initial Public Offering, the full exercise of the over-allotment option by the underwriters’ and the sale of the Private Placement Warrants, a total of $293,250,000 was placed in the Trust Account and we had $3,377,397 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. Transaction costs amounted to $16,368,261 consisting of $5,750,000 of underwriting fees, $10,062,500 of deferred underwriting fees payable and $555,761 of other offering costs.

As of June 30, 2023 and December 31, 2022, we had marketable securities held in the Trust Account of $99,163,964 and $297,415,415, respectively, consisting of U.S. Treasury Bills with a maturity of 180 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through June 30, 2023, we withdrew $940,707 of interest earned on the Trust Account to pay taxes.

For the six months ended June 30, 2023, cash used in operating activities was $1,285,662 which consisted of the net income of $2,750,375, reduced by interest earned on marketable securities held in the Trust Account of $4,971,568 and offset by changes in operating assets and liabilities, which provided $935,530 of cash from operating activities.

For the six months ended June 30, 2022, cash used in operating activities was $1,760,693 which consisted of the net loss of $598,318, increased by interest earned on marketable securities held in the Trust Account of $379,595 and changes in operating assets and liabilities used $782,780 of cash from operating activities.

For the six months ended June 30, 2023, cash provided by investing activities was $203,223,020 which consisted of cash drawn from the Trust Account for redemptions and taxes of $203,242,313 and $940,707, respectively, partially offset by cash deposited into trust of $960,000.

For the six months ended June 30, 2022, cash used in investing activities was $293,232,344 which consisted of cash deposited in the Trust Account of $293,250,000, partially offset by cash withdrawn from the Trust Account for taxes of $17,656.

For the six months ended June 30, 2023, cash used in financing activities was $202,872,313 which consisted of cash paid from the Trust Account for redemptions of $203,242,313, partially offset by proceeds from notes of $370,000.

For the six months ended June 30, 2022, cash provided by financing activities was $296,040,746 which consisted of the sales of units in the initial public offering, net of underwriting discount of $281,750,000, and proceeds from Sponsor promissory note of $15,035,500, partially offset by repayments of the Sponsor promissory note of $300,000, and payments of offering costs of $444,754.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. We may withdraw interest to pay franchise and income taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of a Business Combination, without interest.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

At June 30, 2023, the Company had cash of $766 and working capital deficit of $787,900.

In connection with the Company’s assessment of going concern considerations in accordance with ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently has less than 12 months from the date these financial statements were issued to complete a Business Combination within the Combination Period (the completion window currently ends on December 31, 2023), the mandatory liquidation requirement that the

Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. Management has determined that the Company may not have funds that are sufficient to fund the working capital needs of the Company until the consummation of an initial Business Combination or the winding up of the Company as stipulated in the Company’s amended and restated certificate of incorporation. The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. These unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In connection with the redemption, the Company recorded excise tax of $2.0 million. To the extent the Company issues shares during the year ended December 31, 2023, including in connection with the business combination noted below, it likely will reduce the excise tax liability.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

As of June 30, 2023, we do not have any long-term debt, lease obligations, operating lease obligations or long-term liabilities.

The underwriters will be entitled to a deferred fee of $0.35 per Unit, or $10,062,500 in the aggregate. The deferred fee will be waived by the underwriters in the event that we do not complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates and Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. A critical accounting estimate to our financial statements include valuation of warrants and valuation of allowance for taxes. We have identified the following critical accounting policies:

Class A Common Stock Subject to Possible Redemption

We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in ASC 480 Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our balance sheet.

Warrants

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own Class A common stock among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

All of the Company’s warrants have met the criteria for equity treatment.

Convertible Promissory Notes

Offering Costs associated with Initial Public Offering

The Company complies with the requirements of the FASB ASC 340-10-S99-1 and SAB Topic 5A, “Expenses of Offering.” Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Units were allocated between temporary equity and the Public Warrants by the relative fair value method. Offering costs of $555,761 consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $15,812,500, were allocated between temporary equity, the Public Warrants and the Private Warrants in a relative fair value method upon completion of the Initial Public Offering.

Net Income (Loss) per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. The remeasurement adjustment associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted earnings per share of common stock is the same as basic earnings per common stock for the periods presented. As of June 30, 2023 and December 31, 2022, the warrants are exercisable to purchase 29,410,500 shares of Class A common stock in the aggregate.

Fair Value of Financial Instruments

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Income Taxes

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk. As of June 30, 2023, we were not subject to any market or interest rate risk.

Item 4.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, are recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current Chief Executive Officer and Chief Financial Officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of June 30, 2023, and noted the following deficiency that we believe to be material weaknesses in internal controls over financial reporting as (i) the Company’s processes to ensure its financial statements were properly presented in accordance with GAAP did not operate effectively. Based upon that evaluation, our Certifying Officers concluded that, as of June 30, 2023, our disclosure controls and procedures were not effective.

During the three and six months ended June 30, 2023, we have sought to remediate this material weakness by, among other things, devoting additional resources to the improvement of our internal control over financial reporting as it relates to the accounting treatment for complex financial instruments. While we have processes to identify and appropriately apply applicable accounting requirements, we are enhancing these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our securities and financial statements. We have also added additional layers of management oversight on the accrual of operating expenses and valuation of complex financial instruments. As we continue to evaluate and improve our internal control over financial reporting, management will review and make necessary changes to the overall design of our internal controls.

If we identify any new material weakness in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Management’s Report on Internal Controls Over Financial Reporting

This Quarterly Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies or emerging growth companies.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2023 covered by this Quarterly Report on Form 10-Q, other than the circumstances described above, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

Item 1.

Legal Proceedings.

None.

Item 1A.

Risk Factors.

Factors that could cause the Company’s actual business, financial condition and/or results of operations to differ materially from those in this Quarterly Report are any of the risks factors described in our annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 31, 2023. Any of these risk factors could result in a significant or material adverse effect on the Company’s business, financial condition and/or results of operations. Additional risk factors not presently known to the Company or that the Company currently deems immaterial may also impair the Company’s business, financial condition and/or results of operations.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

On January 11, 2022, we completed our Initial Public Offering of 28,750,000 units at a price of $10.00 per unit, generating gross proceeds of $287,500,000. Each unit consists of one of the Company’s shares of Class A common stock, par value $0.0001 per share, and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. Following the closing of the Initial Public Offering, an aggregate of $293,250,000 was placed in the Trust Account.

Concurrently with the completion of the Initial Public Offering, our sponsor purchased an aggregate of 15,035,500 warrants at a price of $1.00 per warrant, or $15,035,500 in the aggregate. An aggregate of $293,250,000 was placed in a Trust Account at the time of closing of the Initial Public Offering. Each whole Private Placement Warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments.

On January 11, 2022, the underwriters fully exercised their option to purchase additional units. The exercise of the option generated gross proceeds of $37,500,000 to the Company.

Item 3.

Defaults Upon Senior Securities.

None.

Item 4.

Mine Safety Disclosures.

Not applicable.

Item 5.

Other Information.

None.

Item 6.

Exhibits


No.		Description of Exhibit

31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		Inline XBRL Instance Document-this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

*	Filed herewith.

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended, and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.

PART III-SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 13, 2023


C5 ACQUISITION CORPORATION

By:		/s/ Robert Meyerson
		Robert Meyerson
		Chief Executive Officer and Director (Principal Executive Officer)

By:		/s/ David Glickman
		David Glickman
		Chief Business Development Officer and Chief Financial Officer (Principal Financial and Accounting Officer)

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

C5 Acquisition Corp 10-Q